CXCL8 and prostate carcinoma: Mechanistically, we observed that IL-8/CXCR2 signalling promotes prostate cancer cells to secrete ω−3/6 PUFAs, which are taken up by macrophages via CD36 and contribute to M2 polarization, thus fostering an immunosuppressive TME.